Developing Reliable Analytical Strategies to Support Robust Manufacturing Regimes for Cancer Cell Therapies
Time: 11:00 am
day: Pre-Conference Workshop Day
With the cell therapy industry constantly producing innovative engineering and targeting approaches to enable success in solid tumor indications, it is only a matter of time before clinical approval. However, the manufacturing bottlenecks remain an ongoing challenge.
Developing robust, standardized and scalable manufacturing processes which align with regulatory requirements must be considered at this stage to bring any success at clinical trials to the wider patient population.
This session will discuss:
- Mapping out robust manufacturing methods for different cell types and targeting functions
- Strategizing methods to automate manufacturing process to standardize cell therapy treatment, resulting in the consistency of cell products
- Creating more efficient manufacturing through minimizing the operating times and chance of human error